<p>Initial response (A) and initial cure (B) rates with Sb<sup>v</sup> intralesional therapy in New World leishmaniasis studies.</p
Objective: The objective of this study is to compare the efficacy and safety of Intralesional Meglum...
BackgroundMucosal or mucocutaneous leishmaniasis is the most severe form of tegumentary leishmaniasi...
The first choice drugs for the treatment of cutaneous and mucocutaneous leishmaniasis are pentavalen...
The mainstays of cutaneous leishmaniasis (CL) treatment, in several world regions, are pentavalent a...
Abstract. We evaluated the effectiveness and safety of intralesional meglumine antimoniate (MA) in 2...
Although intralesional meglumine antimoniate (MA) infiltration is considered an option for cutaneous...
utaneous leishmaniasis (CL) is a specific skin infection caused by Leishmania parasite and is endemi...
Abstract: Acute Cutaneous Leishmaniasis (ACL) is an endemic disease in developing countries. The fi...
Abstract Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to Colombia....
Background: Intralesional sodium stibogluconate (SSG) has become first line therapy for localized cu...
acute cutaneous leishmaniasis(ACL) is an endemic disease in developing countries.the first line drug...
Abstract INTRODUCTION: Intralesional treatment for cutaneous leishmaniasis has been applied for ove...
BACKGROUND Despite its recognised toxicity, antimonial therapy continues to be the first-line drug f...
The standard of care for cutaneous leishmaniasis includes the intramuscular/intravenous administrati...
Abstract. Two hundred twenty-six consecutive adult patients with cutaneous leishmaniasis in Colombia...
Objective: The objective of this study is to compare the efficacy and safety of Intralesional Meglum...
BackgroundMucosal or mucocutaneous leishmaniasis is the most severe form of tegumentary leishmaniasi...
The first choice drugs for the treatment of cutaneous and mucocutaneous leishmaniasis are pentavalen...
The mainstays of cutaneous leishmaniasis (CL) treatment, in several world regions, are pentavalent a...
Abstract. We evaluated the effectiveness and safety of intralesional meglumine antimoniate (MA) in 2...
Although intralesional meglumine antimoniate (MA) infiltration is considered an option for cutaneous...
utaneous leishmaniasis (CL) is a specific skin infection caused by Leishmania parasite and is endemi...
Abstract: Acute Cutaneous Leishmaniasis (ACL) is an endemic disease in developing countries. The fi...
Abstract Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to Colombia....
Background: Intralesional sodium stibogluconate (SSG) has become first line therapy for localized cu...
acute cutaneous leishmaniasis(ACL) is an endemic disease in developing countries.the first line drug...
Abstract INTRODUCTION: Intralesional treatment for cutaneous leishmaniasis has been applied for ove...
BACKGROUND Despite its recognised toxicity, antimonial therapy continues to be the first-line drug f...
The standard of care for cutaneous leishmaniasis includes the intramuscular/intravenous administrati...
Abstract. Two hundred twenty-six consecutive adult patients with cutaneous leishmaniasis in Colombia...
Objective: The objective of this study is to compare the efficacy and safety of Intralesional Meglum...
BackgroundMucosal or mucocutaneous leishmaniasis is the most severe form of tegumentary leishmaniasi...
The first choice drugs for the treatment of cutaneous and mucocutaneous leishmaniasis are pentavalen...
DOI
Add to ORKG